AI-Powered News Analysis•Compare coverage across the political spectrum
GoodPointsNews
Admin
Back to Dashboard
Lilly's experimental drug cuts weight by 21% in diabetes trial - reuters.com

Lilly's experimental drug cuts weight by 21% in diabetes trial - reuters.com

Lilly's experimental drug cuts weight by 21% in diabetes trial reuters.com

September 29, 2026 at 10:15 PM Original source
1 agencies covered this story

Coverage by Political Leaning

See how different sides of the spectrum reported this story

Left
0 articles
No coverage
Lean Left
0 articles
No coverage
Center
1 articles
Lean Right
0 articles
No coverage
Right
0 articles
No coverage

Key People

No people linked to this story

Locations

USA

Tags

clinical trial diabetes experimental drug lilly weight loss

All Coverage

Lilly's experimental drug cuts weight by 21% in diabetes trial - reuters.com
Reutersvia rss

<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxOdmJvRVgxMnhYOXRRX3pwUGtKYXZic2pPbnhZTGp5SzVHbDR3M1ZQdlRkTFc2eW1NNnh3bkduWTh1MExJTXB6dTRidXNjdVBCVHJZT3lsWXJ2TWluQ2h6Rm5kTUxadFB4RzB3cUUxWFNzVmlkcmp4WXdEb2RWYy1TZkJQOFVHbGY2RnJHOHhPbjBvdmNqeFNWYmFLVkM0SzFySmo4ZTRfZ1NvN0NzRVZlMENDNlNRSlF3Y0RiREo3MzBFSGxBdDRNaA?oc=5" target="_blank">Lilly's experimental drug cuts weight by 21% in diabetes trial</a>&nbsp;&nbsp;<font color="#6f6f6f">reuters.com</font>

100%

Similar Stories

Related coverage based on topic and tags

Argenx discontinues Vyvgart study in Sjögren's disease, shares tumble - Reuters

Argenx discontinues Vyvgart study in Sjögren's disease, shares tumble Reuters

October 8, 2026 at 08:49 PM

Gate Bioscience expands Lilly drug discovery deal worth more than $870 million - Reuters

Gate Bioscience expands Lilly drug discovery deal worth more than $870 million Reuters

October 5, 2026 at 01:55 PM

Regeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial - reuters.com

Regeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial reuters.com

September 30, 2026 at 10:30 PM

Experimental Lilly combination drug tops Zepbound in weight-loss trial - Reuters

Experimental Lilly combination drug tops Zepbound in weight-loss trial Reuters

September 30, 2026 at 05:34 PM

Patients switching to Novo Nordisk's Wegovy pill from shots lose more weight in real-world study - Reuters

Patients switching to Novo Nordisk's Wegovy pill from shots lose more weight in real-world study Reuters

September 30, 2026 at 09:57 AM

Endometriosis trial gives hope to millions of women in pain like me

A £2.3m study will look at whether a personalised pain management plan can improve the quality of life of women who have the debilitating condition.

September 30, 2026 at 05:21 AM